Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys

Cell Transplantation

Volumn 1, Issue 2-3, 1992, Pages 235-244

  Law, Peter K ^a   Goodwin, Tena G ^a   Fang, Qiuwen ^a   Duggirala, Vijaya ^a   Larkin, Charles ^a   Florendo, J Ann ^a   Kirby, Dana S ^a   Deering, Mary Beth ^a   Li, H J ^a   Chen, Ming ^a   Yoo, T J ^a   Cornett, Jennifer ^a   Li, Lawrence M ^a   Shirzad, Afshin ^a   Quinley, Thomas ^a   Holcomb, Randall L ^a  

^a Cell Transplants International LLC   (United States)

Author keywords

Duchenne muscular dystrophy; Myoblast transfer; Phase II clinical trial

Indexed keywords

CYCLOSPORIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CYTOLOGY; FOLLOW UP; HUMAN; MALE; METHODOLOGY; MULTICENTER STUDY; MUSCLE; MUSCULAR DYSTROPHY; PATHOPHYSIOLOGY; PHASE 2 CLINICAL TRIAL; TISSUE CULTURE; TRANSPLANTATION;

ADOLESCENT; CHILD; CYCLOSPORINE; FOLLOW-UP STUDIES; HUMAN; MALE; MUSCLES; MUSCULAR DYSTROPHIES; SUPPORT, NON-U.S. GOV'T; TISSUE CULTURE;

EID: 0027010442     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1177/0963689792001002-305     Document Type: Article

References (34)